Chiesi USA, Inc. – Strategic SWOT Analysis Review

Date: 2016-01

“Chiesi USA, Inc. – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.


– Business description – A detailed description of the company’s operations and business divisions.
– Corporate strategy – GlobalData’s summarization of the company’s business strategy.
– SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
– Company history – Progression of key events associated with the company.
– Major products and services – A list of major products, services and brands of the company.
– Key competitors – A list of key competitors to the company.
– Key employees – A list of the key executives of the company.
– Executive biographies – A brief summary of the executives’ employment history.
– Key operational heads – A list of personnel heading key departments/functions.
– Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
– Key manufacturing facilities – A list of key manufacturing facilities of the company.


Chiesi USA, Inc. (Chiesi USA), formerly Cornerstone Therapeutics Inc., is a specialty pharmaceutical company. It operates as a wholly-owned subsidiary of Chiesi Farmaceutici S.p.A. The company research, development, production and commercialization of innovative products in the areas such as ardiovascular, respiratory, neonatology, rare disease and special care therapeutics. It focuses on commercial and development efforts in the hospital and adjacent specialty product within US. The company’s product portfolio comprises, Cardene I.V., Curosurf, Zyflo, Bethkis and Retavase. It offers products to retail pharmacy chains, wholesalers, group purchasing organizations, hospital systems and specialty pharmacies. The company markets approved generic products through the wholly-owned subsidiary, Aristos Pharmaceuticals, Inc. Chiesi USA is headquartered at Cary, North Carolina, the US.

Chiesi USA, Inc. Key Recent Developments

Nov 07, 2013: Cornerstone Therapeutics Reports Third Quarter 2013 Financial Results
Oct 31, 2013: Cornerstone Therapeutics to Host Third Quarter 2013 Conference Call
Aug 06, 2013: Cornerstone Therapeutics Reports Second Quarter 2013 Financial Results
Jul 30, 2013: Cornerstone Therapeutics to Host Second Quarter 2013 Conference Call
May 09, 2013: Cornerstone Therapeutics Reports Revenue Of $38m In Q1 2013

Reasons to Buy

– Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
– Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
– Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
– Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.”


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample